Perry J.J. van Genderen

Author

Also Known As

Abraham Goorhuis, Cecile Ficko, G. McKinley, Genderen, Perry, Hiroshi Mohri, Martin Grobusch, P J J van Genderen, P J Van Genderen, P J van Genderen, P van Genderen

201

Publications

6.7K

Citations

H-Index

104

Concepts

All Affiliations

Erasmus MC Harbour BioMed (Netherlands)University of Amsterdam Amsterdam UMC Location University of Amsterdam Havenziekenhuis Rotterdam

About

Perry J.J. van Genderen is an author at Erasmus MC specializing in medicine, epidemiology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	1.8K
2	Public Health	10	10	943
3	Health Sciences	7	7	321
4	Allergy	2	2	100
5	Biochemistry	2	2	25

Perry J.J. van Genderen

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study Maris S. Arcilla, Jarne M. van Hattem, Manon Haverkate, The Lancet Infectious Diseases AntibioticsMedicineFoodborne PathogensTraveler DiarrheaFood Microbiology	2016	448
Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restriction Sébastien Matamoros, Jarne M. van Hattem, Maris S. Arcilla, Scientific Reports	2017	255
Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation Patricia Schlagenhauf, Leisa Weld, Abraham Goorhuis, The Lancet Infectious Diseases Infectious Disease EpidemiologyEmerging Infectious DiseasesHealthcare-associated InfectionClinical EpidemiologyInternational Health	2014	244
von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation Jan A. van Mourik, Ria C. Boertjes, I.A. Huisveld, Blood	1999	205
Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin Perry J.J. van Genderen, Paul Mulder, Marco Waleboer, British Journal of Haematology	1997	149
A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination Rosanne W. Wieten, Emile F.F. Jonker, Ester M. M. van Leeuwen, PLoS ONE	2016	109
Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium Annemarie Rosan Kreeftmeijer-Vegter, Perry J.J. van Genderen, Leo G. Visser, Malaria Journal	2012	105
Fatal Yellow Fever in Travelers to Brazil, 2018 Davidson H. Hamer, Kristina M Angelo, Éric Caumes, MMWR Morbidity and Mortality Weekly Report Virus EpidemiologySão PauloEpidemiological DynamicDisease OutbreakFatal Yellow Fever	2018	100
Arterial Thrombophilia in Primary Thrombocythemia Perry J.J. van Genderen, Jan Michiels Angiology Parallel GroupsPain MedicinePharmacotherapyD500 GroupThrombosis	1994	92
Imported Mayaro virus infection in the Netherlands Robert‐Jan Hassing, Isabelle Leparc-Goffart, Sybrandus N. Blank, Journal of Infection Virus EpidemiologyEmergent VirusVirologyMayaro Virus InfectionVirus Transmission	2010	91

Page 1